Vaxxas
Deborah Pascoe, PhD, GAICD, is an experienced professional who has held various leadership positions in the biotechnology and healthcare industry. Deborah is currently the Head of Early Stage and RNA Programs at Vaxxas, where Deborah is involved in commercializing technology to enhance vaccine performance. Previously, Deborah has held roles such as Vice President of Operations at Culture Biosciences and System1 Biosciences, as well as Director positions at Zymergen, Inc. and 23andMe. With a background in Chemical Engineering, Deborah has a proven track record of leadership and innovation in the field.
This person is not in any offices
Vaxxas
Needle-free vaccination and vaccine delivery solutions that safely and cost effectively amplify vaccine efficacy using Nanopatch technology developed by Vaxxas.